How do results from NSABP B-39 influence your practice for APBI compared to WBI in early stage breast cancer?

With respect to clinical outcomes, the results of B-39 confirm what the data previously available demonstrated. APBI is an appropriate option for appropriately selected patients. A less than 5% recurrence at 10 years is excellent and paired with the updated RAPID results provide confidence that part...